+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Digital Biomanufacturing Market by Product Type, Process Stage, Technology, End User, Application - Global Forecast to 2030- Product Image
Digital Biomanufacturing Market by Product Type, Process Stage, Technology, End User, Application - Global Forecast to 2030- Product Image
Sale

Digital Biomanufacturing Market by Product Type, Process Stage, Technology, End User, Application - Global Forecast to 2030

  • PDF Icon

    Report

  • 185 Pages
  • May 2025
  • Region: Global
  • 360iResearch™
  • ID: 5925083
UP TO OFF until Dec 31st 2025
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The Digital Biomanufacturing Market grew from USD 18.97 billion in 2024 to USD 20.90 billion in 2025. It is expected to continue growing at a CAGR of 9.75%, reaching USD 33.16 billion by 2030.

Navigating the Dawn of Digital Biomanufacturing

Digital biomanufacturing represents a fundamental shift in the way biological products are conceived, developed, and delivered. This emerging paradigm leverages advanced automation, data analytics, and modular process design to streamline production and enhance product consistency. As global demand for complex biologics continues to outpace traditional manufacturing capacity, the adoption of digital tools-from real-time process monitoring to adaptive control systems-is enabling manufacturers to accelerate development timelines and reduce costs.

The convergence of digital technologies with bioprocessing platforms also fosters greater flexibility, allowing facilities to switch between products with minimal downtime and reconfiguration. This agility supports a more responsive supply chain capable of addressing volatile market needs, emerging disease threats, and personalized therapies. Moreover, digital biomanufacturing enhances traceability and data integrity, reinforcing compliance with stringent regulatory standards and bolstering confidence among stakeholders. As the biopharmaceutical landscape becomes increasingly competitive, organizations investing in digital transformation are positioned to deliver higher-quality therapies faster and at lower cost, ultimately improving patient outcomes on a global scale.

Emerging Forces Redefining Biomanufacturing Paradigms

The landscape of biomanufacturing is experiencing a cascade of transformative shifts driven by innovations that transcend traditional process boundaries. Automation and machine learning are redefining upstream and downstream operations, enabling predictive maintenance, dynamic process control, and continuous optimization. This shift accelerates throughput while minimizing variability, empowering facilities to operate with unprecedented precision.

Concurrently, single-use technologies are gaining traction, reducing cleaning validation burdens and allowing rapid line changes. Modular facility designs further complement this trend, offering scalable footprints that can be deployed closer to patient populations or integrated into decentralized manufacturing networks. The integration of digital twins-virtual replicas of physical processes-facilitates scenario modeling and risk mitigation, enhancing decision-making and strategic planning.

Together, these trends are dismantling the silos that have historically separated R&D, manufacturing, and quality assurance. A holistic, data-driven approach is emerging, in which information flows seamlessly from laboratory benches to production floors. This convergence lays the groundwork for a resilient, agile biomanufacturing ecosystem capable of meeting growing therapeutic demand while optimizing resource utilization and sustainability.

How 2025 US Tariffs Reshape Biomanufacturing Economics

The introduction of new United States tariffs in 2025 has introduced significant headwinds for biomanufacturing supply chains. Duties imposed on critical raw materials, consumables, and equipment components have elevated input costs, compelling manufacturers to reassess supplier portfolios and operational footprints. The cumulative impact of these measures extends beyond direct price increases; it also necessitates strategic adjustments in inventory management, contract negotiations, and process sourcing.

As organizations navigate the elevated tariff environment, many are exploring near-shoring opportunities and diversifying import channels to mitigate exposure. Strategic stockpiling of essential reagents and single-use components has emerged as a short-term response, though it carries increased carrying costs and potential supply risks. In parallel, collaborative procurement agreements are gaining prominence, allowing consortiums of manufacturers to leverage volume discounts and shared logistics.

These tariff-driven dynamics are fostering a deeper focus on value engineering within process design, spurring innovation in materials selection and process intensification. By embracing digital analytics and scenario modeling, companies can evaluate alternative workflows and supplier configurations that balance cost efficiency with operational resilience.

Unveiling Market Dynamics Through Strategic Segmentation

Unveiling the underlying dynamics of the digital biomanufacturing market requires a multifaceted segmentation lens that captures product, process, technology, end user, and application dimensions. When analyzed through the prism of product type, the market spans Cell Therapy, Monoclonal Antibodies, Recombinant Proteins, and Vaccines, with Cell Therapy further dissected into Car-T Therapy, Stem Cell Therapy, and Tissue Engineering. Examined by process stage, industry participants navigate Continuous Biomanufacturing, Downstream Processing, and Upstream Processing, in which Continuous Biomanufacturing bifurcates into Continuous Downstream and Continuous Upstream, Downstream Processing branches into Chromatography and Filtration, and Upstream Processing encompasses Bioreactors, Cell Culture, and Media.

A technology perspective contrasts Single-Use Systems and Traditional Systems, with Single-Use Systems further defined by Bags, Connectors, and Sensors, and Traditional Systems comprised of Clean-In-Place Systems and Stainless-Steel Bioreactors. From an end-user standpoint, the ecosystem is composed of Academic Organizations, Biopharmaceutical Companies, Contract Development and Manufacturing Organizations, and Research Institutes, with Academic Organizations segmented into Government Research Labs and Universities. Finally, application segmentation spans Diagnostics, Industrial Enzymes, and Therapeutics, where Diagnostics subdivides into Imaging and In Vitro Testing. This layered framework reveals that growth often originates at the intersection of high-value cell therapies, continuous processing modalities, and single-use technologies, while adjacencies in academia and contract manufacturing drive early adoption and scale.

Regional Landscapes Driving Biomanufacturing Growth

Geographic trends exert a profound influence on the evolution of digital biomanufacturing, as regional policies, infrastructure, and talent pools shape investment priorities and adoption curves. In the Americas, established biopharma hubs drive demand for cutting-edge process intensification and digital workflows, underpinned by a robust venture capital ecosystem and agile regulatory pathways. This environment catalyzes rapid commercialization of next-generation therapies and scalable modular facilities.

The Europe, Middle East & Africa region is characterized by a mosaic of regulatory frameworks and a burgeoning commitment to sustainable manufacturing. European Union directives on digital quality infrastructure and data interoperability encourage the integration of real-time analytics and cloud-based platforms. In parallel, emerging markets within the Middle East and Africa are channeling investments into bioprocessing education and strategic partnerships, laying the groundwork for future regional supply capabilities.

Across Asia-Pacific, government-backed biomanufacturing clusters and favorable trade agreements empower local and multinational companies to co-develop digital solutions. Rapid urbanization and rising healthcare demand spur capacity expansions, while emphasis on single-use systems and modular designs addresses resource constraints and logistical complexities. This confluence of factors positions the region as a critical node in global supply chains.

Competitive Highlights of Leading Biomanufacturing Stakeholders

The competitive arena of digital biomanufacturing is anchored by organizations that combine deep domain expertise with strategic investments in automation, analytics, and single-use solutions. Leading players are forging collaborations with academic institutions and contract manufacturers to accelerate validation cycles and co-innovate on modular facility designs. These alliances often yield integrated offerings that reduce time-to-market and lower operational risk for end users.

Furthermore, select companies are differentiating through proprietary digital twins and predictive control platforms that enable real-time process adjustments. By embedding machine learning algorithms within production lines, they can detect deviations early, optimize yields, and assure consistent product quality. In parallel, several firms are expanding their footprints via targeted acquisitions of sensor manufacturers and automation software providers, reinforcing their positions as end-to-end solution partners.

This competitive dynamic is not solely defined by technology portfolios; service excellence and regulatory support have emerged as critical differentiators. Providers that offer end-to-end consulting-from facility design through validation-are securing long-term partnerships, as customers prioritize integrated roadmaps over standalone components.

Strategic Imperatives for Pioneering Biomanufacturers

Industry leaders must adopt a forward-looking posture that aligns digital investments with broader strategic imperatives. Embedding advanced analytics within every stage of the workflow will be essential to drive continuous improvement and foster a culture of data-driven decision-making. Investment in digital twin technologies should be prioritized, as they enable virtual experimentation, risk mitigation, and accelerated process scale-up.

To counter tariff pressures and supply chain volatility, organizations should diversify procurement strategies and explore near-shore manufacturing partnerships. Co-investing in flexible, modular facilities near key markets can reduce dependency on cross-border logistics and circumvent trade disruptions. Simultaneously, fostering collaborative ecosystems with academia and contract development partners will unlock new avenues for innovation while sharing development risk.

Finally, executive teams should champion cross-functional alignment among R&D, quality, and manufacturing groups. A unified governance structure, underpinned by transparent data sharing, will ensure that digital transformation projects deliver on cost efficiency, compliance, and speed to market.

Rigorous Approach Underpinning the Analysis

This analysis is underpinned by a rigorous, multi-method research framework that integrates both primary and secondary data sources. Comprehensive interviews with senior executives, process engineers, and regulatory experts provided nuanced perspectives on emerging trends and strategic priorities. These insights were augmented by a systematic review of published literature, patent filings, and regulatory filings to contextualize technological advancements and policy shifts.

Market segmentation and regional breakdowns were validated through transactional data, company financials, and real-world case studies. Quantitative findings were triangulated with qualitative feedback from key opinion leaders to ensure robust interpretations. All data points underwent stringent quality checks, including cross-source verification and consistency analysis, to minimize biases and uphold analytical integrity.

Through this methodical approach, the study delivers actionable intelligence that reflects the current state of digital biomanufacturing while anticipating future shifts in technology, regulation, and market structure.

Synthesizing Insights for Strategic Advantage

The convergence of digital innovation, evolving regulatory landscapes, and shifting trade dynamics has set the stage for a new era in biomanufacturing. Organizations that harness the power of advanced analytics, continuous processing, and modular technologies will unlock unparalleled efficiency and flexibility. Meanwhile, strategic responses to tariff changes and supply chain disruptions will differentiate resilient operators from those constrained by legacy frameworks.

By leveraging a comprehensive segmentation lens, the market’s multifaceted growth drivers and adoption patterns become clear. Regional insights further illustrate the diverse pathways through which digital biomanufacturing is scaling globally. Competitive intelligence underscores the importance of integrated offerings and service excellence as key differentiators.

Taken together, these insights point to a future in which data-driven, decentralized, and collaborative manufacturing ecosystems become the norm. Stakeholders that proactively align technological investments, operational strategies, and strategic partnerships will be best positioned to lead this transformative journey.

Market Segmentation & Coverage

This research report categorizes to forecast the revenues and analyze trends in each of the following sub-segmentations:
  • Product Type
    • Cell Therapy
      • Car-T Therapy
      • Stem Cell Therapy
      • Tissue Engineering
    • Monoclonal Antibodies
    • Recombinant Proteins
    • Vaccines
  • Process Stage
    • Continuous Biomanufacturing
      • Continuous Downstream
      • Continuous Upstream
    • Downstream Processing
      • Chromatography
      • Filtration
    • Upstream Processing
      • Bioreactors
      • Cell Culture
      • Media
  • Technology
    • Single-Use Systems
      • Bags
      • Connectors
      • Sensors
    • Traditional Systems
      • Clean-In-Place Systems
      • Stainless-Steel Bioreactors
  • End User
    • Academic Organizations
      • Government Research Labs
      • Universities
    • Biopharmaceutical Companies
    • Contract Development And Manufacturing Organizations
    • Research Institutes
  • Application
    • Diagnostics
      • Imaging
      • In Vitro Testing
    • Industrial Enzymes
    • Therapeutics
This research report categorizes to forecast the revenues and analyze trends in each of the following sub-regions:
  • Americas
    • United States
      • California
      • Texas
      • New York
      • Florida
      • Illinois
      • Pennsylvania
      • Ohio
    • Canada
    • Mexico
    • Brazil
    • Argentina
  • Europe, Middle East & Africa
    • United Kingdom
    • Germany
    • France
    • Russia
    • Italy
    • Spain
    • United Arab Emirates
    • Saudi Arabia
    • South Africa
    • Denmark
    • Netherlands
    • Qatar
    • Finland
    • Sweden
    • Nigeria
    • Egypt
    • Turkey
    • Israel
    • Norway
    • Poland
    • Switzerland
  • Asia-Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • Indonesia
    • Thailand
    • Philippines
    • Malaysia
    • Singapore
    • Vietnam
    • Taiwan
This research report categorizes to delves into recent significant developments and analyze trends in each of the following companies:
  • Thermo Fisher Scientific Inc.
  • Sartorius AG
  • Merck KGaA
  • Danaher Corporation
  • Eppendorf AG
  • Agilent Technologies, Inc.
  • Bio-Rad Laboratories, Inc.
  • PerkinElmer, Inc.
  • Shimadzu Corporation
  • Rockwell Automation, Inc.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Digital Biomanufacturing Market, by Product Type
8.1. Introduction
8.2. Cell Therapy
8.2.1. Car-T Therapy
8.2.2. Stem Cell Therapy
8.2.3. Tissue Engineering
8.3. Monoclonal Antibodies
8.4. Recombinant Proteins
8.5. Vaccines
9. Digital Biomanufacturing Market, by Process Stage
9.1. Introduction
9.2. Continuous Biomanufacturing
9.2.1. Continuous Downstream
9.2.2. Continuous Upstream
9.3. Downstream Processing
9.3.1. Chromatography
9.3.2. Filtration
9.4. Upstream Processing
9.4.1. Bioreactors
9.4.2. Cell Culture
9.4.3. Media
10. Digital Biomanufacturing Market, by Technology
10.1. Introduction
10.2. Single-Use Systems
10.2.1. Bags
10.2.2. Connectors
10.2.3. Sensors
10.3. Traditional Systems
10.3.1. Clean-In-Place Systems
10.3.2. Stainless-Steel Bioreactors
11. Digital Biomanufacturing Market, by End User
11.1. Introduction
11.2. Academic Organizations
11.2.1. Government Research Labs
11.2.2. Universities
11.3. Biopharmaceutical Companies
11.4. Contract Development and Manufacturing Organizations
11.5. Research Institutes
12. Digital Biomanufacturing Market, by Application
12.1. Introduction
12.2. Diagnostics
12.2.1. Imaging
12.2.2. in Vitro Testing
12.3. Industrial Enzymes
12.4. Therapeutics
13. Americas Digital Biomanufacturing Market
13.1. Introduction
13.2. United States
13.3. Canada
13.4. Mexico
13.5. Brazil
13.6. Argentina
14. Europe, Middle East & Africa Digital Biomanufacturing Market
14.1. Introduction
14.2. United Kingdom
14.3. Germany
14.4. France
14.5. Russia
14.6. Italy
14.7. Spain
14.8. United Arab Emirates
14.9. Saudi Arabia
14.10. South Africa
14.11. Denmark
14.12. Netherlands
14.13. Qatar
14.14. Finland
14.15. Sweden
14.16. Nigeria
14.17. Egypt
14.18. Turkey
14.19. Israel
14.20. Norway
14.21. Poland
14.22. Switzerland
15. Asia-Pacific Digital Biomanufacturing Market
15.1. Introduction
15.2. China
15.3. India
15.4. Japan
15.5. Australia
15.6. South Korea
15.7. Indonesia
15.8. Thailand
15.9. Philippines
15.10. Malaysia
15.11. Singapore
15.12. Vietnam
15.13. Taiwan
16. Competitive Landscape
16.1. Market Share Analysis, 2024
16.2. FPNV Positioning Matrix, 2024
16.3. Competitive Analysis
16.3.1. Thermo Fisher Scientific Inc.
16.3.2. Sartorius AG
16.3.3. Merck KGaA
16.3.4. Danaher Corporation
16.3.5. Eppendorf AG
16.3.6. Agilent Technologies, Inc.
16.3.7. Bio-Rad Laboratories, Inc.
16.3.8. PerkinElmer, Inc.
16.3.9. Shimadzu Corporation
16.3.10. Rockwell Automation, Inc.
17. ResearchAI
18. ResearchStatistics
19. ResearchContacts
20. ResearchArticles
21. Appendix
List of Figures
FIGURE 1. DIGITAL BIOMANUFACTURING MARKET MULTI-CURRENCY
FIGURE 2. DIGITAL BIOMANUFACTURING MARKET MULTI-LANGUAGE
FIGURE 3. DIGITAL BIOMANUFACTURING MARKET RESEARCH PROCESS
FIGURE 4. GLOBAL DIGITAL BIOMANUFACTURING MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 5. GLOBAL DIGITAL BIOMANUFACTURING MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 6. GLOBAL DIGITAL BIOMANUFACTURING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL DIGITAL BIOMANUFACTURING MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2030 (%)
FIGURE 8. GLOBAL DIGITAL BIOMANUFACTURING MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL DIGITAL BIOMANUFACTURING MARKET SIZE, BY PROCESS STAGE, 2024 VS 2030 (%)
FIGURE 10. GLOBAL DIGITAL BIOMANUFACTURING MARKET SIZE, BY PROCESS STAGE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL DIGITAL BIOMANUFACTURING MARKET SIZE, BY TECHNOLOGY, 2024 VS 2030 (%)
FIGURE 12. GLOBAL DIGITAL BIOMANUFACTURING MARKET SIZE, BY TECHNOLOGY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL DIGITAL BIOMANUFACTURING MARKET SIZE, BY END USER, 2024 VS 2030 (%)
FIGURE 14. GLOBAL DIGITAL BIOMANUFACTURING MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. GLOBAL DIGITAL BIOMANUFACTURING MARKET SIZE, BY APPLICATION, 2024 VS 2030 (%)
FIGURE 16. GLOBAL DIGITAL BIOMANUFACTURING MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. AMERICAS DIGITAL BIOMANUFACTURING MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 18. AMERICAS DIGITAL BIOMANUFACTURING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. UNITED STATES DIGITAL BIOMANUFACTURING MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 20. UNITED STATES DIGITAL BIOMANUFACTURING MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. EUROPE, MIDDLE EAST & AFRICA DIGITAL BIOMANUFACTURING MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 22. EUROPE, MIDDLE EAST & AFRICA DIGITAL BIOMANUFACTURING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 23. ASIA-PACIFIC DIGITAL BIOMANUFACTURING MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 24. ASIA-PACIFIC DIGITAL BIOMANUFACTURING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 25. DIGITAL BIOMANUFACTURING MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 26. DIGITAL BIOMANUFACTURING MARKET, FPNV POSITIONING MATRIX, 2024
List of Tables
TABLE 1. DIGITAL BIOMANUFACTURING MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL DIGITAL BIOMANUFACTURING MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL DIGITAL BIOMANUFACTURING MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. GLOBAL DIGITAL BIOMANUFACTURING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 6. GLOBAL DIGITAL BIOMANUFACTURING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 7. GLOBAL DIGITAL BIOMANUFACTURING MARKET SIZE, BY CELL THERAPY, BY REGION, 2018-2030 (USD MILLION)
TABLE 8. GLOBAL DIGITAL BIOMANUFACTURING MARKET SIZE, BY CAR-T THERAPY, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. GLOBAL DIGITAL BIOMANUFACTURING MARKET SIZE, BY STEM CELL THERAPY, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. GLOBAL DIGITAL BIOMANUFACTURING MARKET SIZE, BY TISSUE ENGINEERING, BY REGION, 2018-2030 (USD MILLION)
TABLE 11. GLOBAL DIGITAL BIOMANUFACTURING MARKET SIZE, BY CELL THERAPY, 2018-2030 (USD MILLION)
TABLE 12. GLOBAL DIGITAL BIOMANUFACTURING MARKET SIZE, BY MONOCLONAL ANTIBODIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 13. GLOBAL DIGITAL BIOMANUFACTURING MARKET SIZE, BY RECOMBINANT PROTEINS, BY REGION, 2018-2030 (USD MILLION)
TABLE 14. GLOBAL DIGITAL BIOMANUFACTURING MARKET SIZE, BY VACCINES, BY REGION, 2018-2030 (USD MILLION)
TABLE 15. GLOBAL DIGITAL BIOMANUFACTURING MARKET SIZE, BY PROCESS STAGE, 2018-2030 (USD MILLION)
TABLE 16. GLOBAL DIGITAL BIOMANUFACTURING MARKET SIZE, BY CONTINUOUS BIOMANUFACTURING, BY REGION, 2018-2030 (USD MILLION)
TABLE 17. GLOBAL DIGITAL BIOMANUFACTURING MARKET SIZE, BY CONTINUOUS DOWNSTREAM, BY REGION, 2018-2030 (USD MILLION)
TABLE 18. GLOBAL DIGITAL BIOMANUFACTURING MARKET SIZE, BY CONTINUOUS UPSTREAM, BY REGION, 2018-2030 (USD MILLION)
TABLE 19. GLOBAL DIGITAL BIOMANUFACTURING MARKET SIZE, BY CONTINUOUS BIOMANUFACTURING, 2018-2030 (USD MILLION)
TABLE 20. GLOBAL DIGITAL BIOMANUFACTURING MARKET SIZE, BY DOWNSTREAM PROCESSING, BY REGION, 2018-2030 (USD MILLION)
TABLE 21. GLOBAL DIGITAL BIOMANUFACTURING MARKET SIZE, BY CHROMATOGRAPHY, BY REGION, 2018-2030 (USD MILLION)
TABLE 22. GLOBAL DIGITAL BIOMANUFACTURING MARKET SIZE, BY FILTRATION, BY REGION, 2018-2030 (USD MILLION)
TABLE 23. GLOBAL DIGITAL BIOMANUFACTURING MARKET SIZE, BY DOWNSTREAM PROCESSING, 2018-2030 (USD MILLION)
TABLE 24. GLOBAL DIGITAL BIOMANUFACTURING MARKET SIZE, BY UPSTREAM PROCESSING, BY REGION, 2018-2030 (USD MILLION)
TABLE 25. GLOBAL DIGITAL BIOMANUFACTURING MARKET SIZE, BY BIOREACTORS, BY REGION, 2018-2030 (USD MILLION)
TABLE 26. GLOBAL DIGITAL BIOMANUFACTURING MARKET SIZE, BY CELL CULTURE, BY REGION, 2018-2030 (USD MILLION)
TABLE 27. GLOBAL DIGITAL BIOMANUFACTURING MARKET SIZE, BY MEDIA, BY REGION, 2018-2030 (USD MILLION)
TABLE 28. GLOBAL DIGITAL BIOMANUFACTURING MARKET SIZE, BY UPSTREAM PROCESSING, 2018-2030 (USD MILLION)
TABLE 29. GLOBAL DIGITAL BIOMANUFACTURING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 30. GLOBAL DIGITAL BIOMANUFACTURING MARKET SIZE, BY SINGLE-USE SYSTEMS, BY REGION, 2018-2030 (USD MILLION)
TABLE 31. GLOBAL DIGITAL BIOMANUFACTURING MARKET SIZE, BY BAGS, BY REGION, 2018-2030 (USD MILLION)
TABLE 32. GLOBAL DIGITAL BIOMANUFACTURING MARKET SIZE, BY CONNECTORS, BY REGION, 2018-2030 (USD MILLION)
TABLE 33. GLOBAL DIGITAL BIOMANUFACTURING MARKET SIZE, BY SENSORS, BY REGION, 2018-2030 (USD MILLION)
TABLE 34. GLOBAL DIGITAL BIOMANUFACTURING MARKET SIZE, BY SINGLE-USE SYSTEMS, 2018-2030 (USD MILLION)
TABLE 35. GLOBAL DIGITAL BIOMANUFACTURING MARKET SIZE, BY TRADITIONAL SYSTEMS, BY REGION, 2018-2030 (USD MILLION)
TABLE 36. GLOBAL DIGITAL BIOMANUFACTURING MARKET SIZE, BY CLEAN-IN-PLACE SYSTEMS, BY REGION, 2018-2030 (USD MILLION)
TABLE 37. GLOBAL DIGITAL BIOMANUFACTURING MARKET SIZE, BY STAINLESS-STEEL BIOREACTORS, BY REGION, 2018-2030 (USD MILLION)
TABLE 38. GLOBAL DIGITAL BIOMANUFACTURING MARKET SIZE, BY TRADITIONAL SYSTEMS, 2018-2030 (USD MILLION)
TABLE 39. GLOBAL DIGITAL BIOMANUFACTURING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 40. GLOBAL DIGITAL BIOMANUFACTURING MARKET SIZE, BY ACADEMIC ORGANIZATIONS, BY REGION, 2018-2030 (USD MILLION)
TABLE 41. GLOBAL DIGITAL BIOMANUFACTURING MARKET SIZE, BY GOVERNMENT RESEARCH LABS, BY REGION, 2018-2030 (USD MILLION)
TABLE 42. GLOBAL DIGITAL BIOMANUFACTURING MARKET SIZE, BY UNIVERSITIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 43. GLOBAL DIGITAL BIOMANUFACTURING MARKET SIZE, BY ACADEMIC ORGANIZATIONS, 2018-2030 (USD MILLION)
TABLE 44. GLOBAL DIGITAL BIOMANUFACTURING MARKET SIZE, BY BIOPHARMACEUTICAL COMPANIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 45. GLOBAL DIGITAL BIOMANUFACTURING MARKET SIZE, BY CONTRACT DEVELOPMENT AND MANUFACTURING ORGANIZATIONS, BY REGION, 2018-2030 (USD MILLION)
TABLE 46. GLOBAL DIGITAL BIOMANUFACTURING MARKET SIZE, BY RESEARCH INSTITUTES, BY REGION, 2018-2030 (USD MILLION)
TABLE 47. GLOBAL DIGITAL BIOMANUFACTURING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 48. GLOBAL DIGITAL BIOMANUFACTURING MARKET SIZE, BY DIAGNOSTICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 49. GLOBAL DIGITAL BIOMANUFACTURING MARKET SIZE, BY IMAGING, BY REGION, 2018-2030 (USD MILLION)
TABLE 50. GLOBAL DIGITAL BIOMANUFACTURING MARKET SIZE, BY IN VITRO TESTING, BY REGION, 2018-2030 (USD MILLION)
TABLE 51. GLOBAL DIGITAL BIOMANUFACTURING MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 52. GLOBAL DIGITAL BIOMANUFACTURING MARKET SIZE, BY INDUSTRIAL ENZYMES, BY REGION, 2018-2030 (USD MILLION)
TABLE 53. GLOBAL DIGITAL BIOMANUFACTURING MARKET SIZE, BY THERAPEUTICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 54. AMERICAS DIGITAL BIOMANUFACTURING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 55. AMERICAS DIGITAL BIOMANUFACTURING MARKET SIZE, BY CELL THERAPY, 2018-2030 (USD MILLION)
TABLE 56. AMERICAS DIGITAL BIOMANUFACTURING MARKET SIZE, BY PROCESS STAGE, 2018-2030 (USD MILLION)
TABLE 57. AMERICAS DIGITAL BIOMANUFACTURING MARKET SIZE, BY CONTINUOUS BIOMANUFACTURING, 2018-2030 (USD MILLION)
TABLE 58. AMERICAS DIGITAL BIOMANUFACTURING MARKET SIZE, BY DOWNSTREAM PROCESSING, 2018-2030 (USD MILLION)
TABLE 59. AMERICAS DIGITAL BIOMANUFACTURING MARKET SIZE, BY UPSTREAM PROCESSING, 2018-2030 (USD MILLION)
TABLE 60. AMERICAS DIGITAL BIOMANUFACTURING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 61. AMERICAS DIGITAL BIOMANUFACTURING MARKET SIZE, BY SINGLE-USE SYSTEMS, 2018-2030 (USD MILLION)
TABLE 62. AMERICAS DIGITAL BIOMANUFACTURING MARKET SIZE, BY TRADITIONAL SYSTEMS, 2018-2030 (USD MILLION)
TABLE 63. AMERICAS DIGITAL BIOMANUFACTURING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 64. AMERICAS DIGITAL BIOMANUFACTURING MARKET SIZE, BY ACADEMIC ORGANIZATIONS, 2018-2030 (USD MILLION)
TABLE 65. AMERICAS DIGITAL BIOMANUFACTURING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 66. AMERICAS DIGITAL BIOMANUFACTURING MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 67. AMERICAS DIGITAL BIOMANUFACTURING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 68. UNITED STATES DIGITAL BIOMANUFACTURING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 69. UNITED STATES DIGITAL BIOMANUFACTURING MARKET SIZE, BY CELL THERAPY, 2018-2030 (USD MILLION)
TABLE 70. UNITED STATES DIGITAL BIOMANUFACTURING MARKET SIZE, BY PROCESS STAGE, 2018-2030 (USD MILLION)
TABLE 71. UNITED STATES DIGITAL BIOMANUFACTURING MARKET SIZE, BY CONTINUOUS BIOMANUFACTURING, 2018-2030 (USD MILLION)
TABLE 72. UNITED STATES DIGITAL BIOMANUFACTURING MARKET SIZE, BY DOWNSTREAM PROCESSING, 2018-2030 (USD MILLION)
TABLE 73. UNITED STATES DIGITAL BIOMANUFACTURING MARKET SIZE, BY UPSTREAM PROCESSING, 2018-2030 (USD MILLION)
TABLE 74. UNITED STATES DIGITAL BIOMANUFACTURING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 75. UNITED STATES DIGITAL BIOMANUFACTURING MARKET SIZE, BY SINGLE-USE SYSTEMS, 2018-2030 (USD MILLION)
TABLE 76. UNITED STATES DIGITAL BIOMANUFACTURING MARKET SIZE, BY TRADITIONAL SYSTEMS, 2018-2030 (USD MILLION)
TABLE 77. UNITED STATES DIGITAL BIOMANUFACTURING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 78. UNITED STATES DIGITAL BIOMANUFACTURING MARKET SIZE, BY ACADEMIC ORGANIZATIONS, 2018-2030 (USD MILLION)
TABLE 79. UNITED STATES DIGITAL BIOMANUFACTURING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 80. UNITED STATES DIGITAL BIOMANUFACTURING MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 81. UNITED STATES DIGITAL BIOMANUFACTURING MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 82. CANADA DIGITAL BIOMANUFACTURING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 83. CANADA DIGITAL BIOMANUFACTURING MARKET SIZE, BY CELL THERAPY, 2018-2030 (USD MILLION)
TABLE 84. CANADA DIGITAL BIOMANUFACTURING MARKET SIZE, BY PROCESS STAGE, 2018-2030 (USD MILLION)
TABLE 85. CANADA DIGITAL BIOMANUFACTURING MARKET SIZE, BY CONTINUOUS BIOMANUFACTURING, 2018-2030 (USD MILLION)
TABLE 86. CANADA DIGITAL BIOMANUFACTURING MARKET SIZE, BY DOWNSTREAM PROCESSING, 2018-2030 (USD MILLION)
TABLE 87. CANADA DIGITAL BIOMANUFACTURING MARKET SIZE, BY UPSTREAM PROCESSING, 2018-2030 (USD MILLION)
TABLE 88. CANADA DIGITAL BIOMANUFACTURING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 89. CANADA DIGITAL BIOMANUFACTURING MARKET SIZE, BY SINGLE-USE SYSTEMS, 2018-2030 (USD MILLION)
TABLE 90. CANADA DIGITAL BIOMANUFACTURING MARKET SIZE, BY TRADITIONAL SYSTEMS, 2018-2030 (USD MILLION)
TABLE 91. CANADA DIGITAL BIOMANUFACTURING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 92. CANADA DIGITAL BIOMANUFACTURING MARKET SIZE, BY ACADEMIC ORGANIZATIONS, 2018-2030 (USD MILLION)
TABLE 93. CANADA DIGITAL BIOMANUFACTURING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 94. CANADA DIGITAL BIOMANUFACTURING MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 95. MEXICO DIGITAL BIOMANUFACTURING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 96. MEXICO DIGITAL BIOMANUFACTURING MARKET SIZE, BY CELL THERAPY, 2018-2030 (USD MILLION)
TABLE 97. MEXICO DIGITAL BIOMANUFACTURING MARKET SIZE, BY PROCESS STAGE, 2018-2030 (USD MILLION)
TABLE 98. MEXICO DIGITAL BIOMANUFACTURING MARKET SIZE, BY CONTINUOUS BIOMANUFACTURING, 2018-2030 (USD MILLION)
TABLE 99. MEXICO DIGITAL BIOMANUFACTURING MARKET SIZE, BY DOWNSTREAM PROCESSING, 2018-2030 (USD MILLION)
TABLE 100. MEXICO DIGITAL BIOMANUFACTURING MARKET SIZE, BY UPSTREAM PROCESSING, 2018-2030 (USD MILLION)
TABLE 101. MEXICO DIGITAL BIOMANUFACTURING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 102. MEXICO DIGITAL BIOMANUFACTURING MARKET SIZE, BY SINGLE-USE SYSTEMS, 2018-2030 (USD MILLION)
TABLE 103. MEXICO DIGITAL BIOMANUFACTURING MARKET SIZE, BY TRADITIONAL SYSTEMS, 2018-2030 (USD MILLION)
TABLE 104. MEXICO DIGITAL BIOMANUFACTURING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 105. MEXICO DIGITAL BIOMANUFACTURING MARKET SIZE, BY ACADEMIC ORGANIZATIONS, 2018-2030 (USD MILLION)
TABLE 106. MEXICO DIGITAL BIOMANUFACTURING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 107. MEXICO DIGITAL BIOMANUFACTURING MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 108. BRAZIL DIGITAL BIOMANUFACTURING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 109. BRAZIL DIGITAL BIOMANUFACTURING MARKET SIZE, BY CELL THERAPY, 2018-2030 (USD MILLION)
TABLE 110. BRAZIL DIGITAL BIOMANUFACTURING MARKET SIZE, BY PROCESS STAGE, 2018-2030 (USD MILLION)
TABLE 111. BRAZIL DIGITAL BIOMANUFACTURING MARKET SIZE, BY CONTINUOUS BIOMANUFACTURING, 2018-2030 (USD MILLION)
TABLE 112. BRAZIL DIGITAL BIOMANUFACTURING MARKET SIZE, BY DOWNSTREAM PROCESSING, 2018-2030 (USD MILLION)
TABLE 113. BRAZIL DIGITAL BIOMANUFACTURING MARKET SIZE, BY UPSTREAM PROCESSING, 2018-2030 (USD MILLION)
TABLE 114. BRAZIL DIGITAL BIOMANUFACTURING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 115. BRAZIL DIGITAL BIOMANUFACTURING MARKET SIZE, BY SINGLE-USE SYSTEMS, 2018-2030 (USD MILLION)
TABLE 116. BRAZIL DIGITAL BIOMANUFACTURING MARKET SIZE, BY TRADITIONAL SYSTEMS, 2018-2030 (USD MILLION)
TABLE 117. BRAZIL DIGITAL BIOMANUFACTURING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 118. BRAZIL DIGITAL BIOMANUFACTURING MARKET SIZE, BY ACADEMIC ORGANIZATIONS, 2018-2030 (USD MILLION)
TABLE 119. BRAZIL DIGITAL BIOMANUFACTURING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 120. BRAZIL DIGITAL BIOMANUFACTURING MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 121. ARGENTINA DIGITAL BIOMANUFACTURING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 122. ARGENTINA DIGITAL BIOMANUFACTURING MARKET SIZE, BY CELL THERAPY, 2018-2030 (USD MILLION)
TABLE 123. ARGENTINA DIGITAL BIOMANUFACTURING MARKET SIZE, BY PROCESS STAGE, 2018-2030 (USD MILLION)
TABLE 124. ARGENTINA DIGITAL BIOMANUFACTURING MARKET SIZE, BY CONTINUOUS BIOMANUFACTURING, 2018-2030 (USD MILLION)
TABLE 125. ARGENTINA DIGITAL BIOMANUFACTURING MARKET SIZE, BY DOWNSTREAM PROCESSING, 2018-2030 (USD MILLION)
TABLE 126. ARGENTINA DIGITAL BIOMANUFACTURING MARKET SIZE, BY UPSTREAM PROCESSING, 2018-2030 (USD MILLION)
TABLE 127. ARGENTINA DIGITAL BIOMANUFACTURING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 128. ARGENTINA DIGITAL BIOMANUFACTURING MARKET SIZE, BY SINGLE-USE SYSTEMS, 2018-2030 (USD MILLION)
TABLE 129. ARGENTINA DIGITAL BIOMANUFACTURING MARKET SIZE, BY TRADITIONAL SYSTEMS, 2018-2030 (USD MILLION)
TABLE 130. ARGENTINA DIGITAL BIOMANUFACTURING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 131. ARGENTINA DIGITAL BIOMANUFACTURING MARKET SIZE, BY ACADEMIC ORGANIZATIONS, 2018-2030 (USD MILLION)
TABLE 132. ARGENTINA DIGITAL BIOMANUFACTURING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 133. ARGENTINA DIGITAL BIOMANUFACTURING MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 134. EUROPE, MIDDLE EAST & AFRICA DIGITAL BIOMANUFACTURING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 135. EUROPE, MIDDLE EAST & AFRICA DIGITAL BIOMANUFACTURING MARKET SIZE, BY CELL THERAPY, 2018-2030 (USD MILLION)
TABLE 136. EUROPE, MIDDLE EAST & AFRICA DIGITAL BIOMANUFACTURING MARKET SIZE, BY PROCESS STAGE, 2018-2030 (USD MILLION)
TABLE 137. EUROPE, MIDDLE EAST & AFRICA DIGITAL BIOMANUFACTURING MARKET SIZE, BY CONTINUOUS BIOMANUFACTURING, 2018-2030 (USD MILLION)
TABLE 138. EUROPE, MIDDLE EAST & AFRICA DIGITAL BIOMANUFACTURING MARKET SIZE, BY DOWNSTREAM PROCESSING, 2018-2030 (USD MILLION)
TABLE 139. EUROPE, MIDDLE EAST & AFRICA DIGITAL BIOMANUFACTURING MARKET SIZE, BY UPSTREAM PROCESSING, 2018-2030 (USD MILLION)
TABLE 140. EUROPE, MIDDLE EAST & AFRICA DIGITAL BIOMANUFACTURING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 141. EUROPE, MIDDLE EAST & AFRICA DIGITAL BIOMANUFACTURING MARKET SIZE, BY SINGLE-USE SYSTEMS, 2018-2030 (USD MILLION)
TABLE 142. EUROPE, MIDDLE EAST & AFRICA DIGITAL BIOMANUFACTURING MARKET SIZE, BY TRADITIONAL SYSTEMS, 2018-2030 (USD MILLION)
TABLE 143. EUROPE, MIDDLE EAST & AFRICA DIGITAL BIOMANUFACTURING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 144. EUROPE, MIDDLE EAST & AFRICA DIGITAL BIOMANUFACTURING MARKET SIZE, BY ACADEMIC ORGANIZATIONS, 2018-2030 (USD MILLION)
TABLE 145. EUROPE, MIDDLE EAST & AFRICA DIGITAL BIOMANUFACTURING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 146. EUROPE, MIDDLE EAST & AFRICA DIGITAL BIOMANUFACTURING MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 147. EUROPE, MIDDLE EAST & AFRICA DIGITAL BIOMANUFACTURING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 148. UNITED KINGDOM DIGITAL BIOMANUFACTURING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 149. UNITED KINGDOM DIGITAL BIOMANUFACTURING MARKET SIZE, BY CELL THERAPY, 2018-2030 (USD MILLION)
TABLE 150. UNITED KINGDOM DIGITAL BIOMANUFACTURING MARKET SIZE, BY PROCESS STAGE, 2018-2030 (USD MILLION)
TABLE 151. UNITED KINGDOM DIGITAL BIOMANUFACTURING MARKET SIZE, BY CONTINUOUS BIOMANUFACTURING, 2018-2030 (USD MILLION)
TABLE 152. UNITED KINGDOM DIGITAL BIOMANUFACTURING MARKET SIZE, BY DOWNSTREAM PROCESSING, 2018-2030 (USD MILLION)
TABLE 153. UNITED KINGDOM DIGITAL BIOMANUFACTURING MARKET SIZE, BY UPSTREAM PROCESSING, 2018-2030 (USD MILLION)
TABLE 154. UNITED KINGDOM DIGITAL BIOMANUFACTURING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 155. UNITED KINGDOM DIGITAL BIOMANUFACTURING MARKET SIZE, BY SINGLE-USE SYSTEMS, 2018-2030 (USD MILLION)
TABLE 156. UNITED KINGDOM DIGITAL BIOMANUFACTURING MARKET SIZE, BY TRADITIONAL SYSTEMS, 2018-2030 (USD MILLION)
TABLE 157. UNITED KINGDOM DIGITAL BIOMANUFACTURING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 158. UNITED KINGDOM DIGITAL BIOMANUFACTURING MARKET SIZE, BY ACADEMIC ORGANIZATIONS, 2018-2030 (USD MILLION)
TABLE 159. UNITED KINGDOM DIGITAL BIOMANUFACTURING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 160. UNITED KINGDOM DIGITAL BIOMANUFACTURING MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 161. GERMANY DIGITAL BIOMANUFACTURING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 162. GERMANY DIGITAL BIOMANUFACTURING MARKET SIZE, BY CELL THERAPY, 2018-2030 (USD MILLION)
TABLE 163. GERMANY DIGITAL BIOMANUFACTURING MARKET SIZE, BY PROCESS STAGE, 2018-2030 (USD MILLION)
TABLE 164. GERMANY DIGITAL BIOMANUFACTURING MARKET SIZE, BY CONTINUOUS BIOMANUFACTURING, 2018-2030 (USD MILLION)
TABLE 165. GERMANY DIGITAL BIOMANUFACTURING MARKET SIZE, BY DOWNSTREAM PROCESSING, 2018-2030 (USD MILLION)
TABLE 166. GERMANY DIGITAL BIOMANUFACTURING MARKET SIZE, BY UPSTREAM PROCESSING, 2018-2030 (USD MILLION)
TABLE 167. GERMANY DIGITAL BIOMANUFACTURING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 168. GERMANY DIGITAL BIOMANUFACTURING MARKET SIZE, BY SINGLE-USE SYSTEMS, 2018-2030 (USD MILLION)
TABLE 169. GERMANY DIGITAL BIOMANUFACTURING MARKET SIZE, BY TRADITIONAL SYSTEMS, 2018-2030 (USD MILLION)
TABLE 170. GERMANY DIGITAL BIOMANUFACTURING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 171. GERMANY DIGITAL BIOMANUFACTURING MARKET SIZE, BY ACADEMIC ORGANIZATIONS, 2018-2030 (USD MILLION)
TABLE 172. GERMANY DIGITAL BIOMANUFACTURING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 173. GERMANY DIGITAL BIOMANUFACTURING MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 174. FRANCE DIGITAL BIOMANUFACTURING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 175. FRANCE DIGITAL BIOMANUFACTURING MARKET SIZE, BY CELL THERAPY, 2018-2030 (USD MILLION)
TABLE 176. FRANCE DIGITAL BIOMANUFACTURING MARKET SIZE, BY PROCESS STAGE, 2018-2030 (USD MILLION)
TABLE 177. FRANCE DIGITAL BIOMANUFACTURING MARKET SIZE, BY CONTINUOUS BIOMANUFACTURING, 2018-2030 (USD MILLION)
TABLE 178. FRANCE DIGITAL BIOMANUFACTURING MARKET SIZE, BY DOWNSTREAM PROCESSING, 2018-2030 (USD MILLION)
TABLE 179. FRANCE DIGITAL BIOMANUFACTURING MARKET SIZE, BY UPSTREAM PROCESSING, 2018-2030 (USD MILLION)
TABLE 180. FRANCE DIGITAL BIOMANUFACTURING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 181. FRANCE DIGITAL BIOMANUFACTURING MARKET SIZE, BY SINGLE-USE SYSTEMS, 2018-2030 (USD MILLION)
TABLE 182. FRANCE DIGITAL BIOMANUFACTURING MARKET SIZE, BY TRADITIONAL SYSTEMS, 2018-2030 (USD MILLION)
TABLE 183. FRANCE DIGITAL BIOMANUFACTURING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 184. FRANCE DIGITAL BIOMANUFACTURING MARKET SIZE, BY ACADEMIC ORGANIZATIONS, 2018-2030 (USD MILLION)
TABLE 185. FRANCE DIGITAL BIOMANUFACTURING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 186. FRANCE DIGITAL BIOMANUFACTURING MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 187. RUSSIA DIGITAL BIOMANUFACTURING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 188. RUSSIA DIGITAL BIOMANUFACTURING MARKET SIZE, BY CELL THERAPY, 2018-2030 (USD MILLION)
TABLE 189. RUSSIA DIGITAL BIOMANUFACTURING MARKET SIZE, BY PROCESS STAGE, 2018-2030 (USD MILLION)
TABLE 190. RUSSIA DIGITAL BIOMANUFACTURING MARKET SIZE, BY CONTINUOUS BIOMANUFACTURING, 2018-2030 (USD MILLION)
TABLE 191. RUSSIA DIGITAL BIOMANUFACTURING MARKET SIZE, BY DOWNSTREAM PROCESSING, 2018-2030 (USD MILLION)
TABLE 192. RUSSIA DIGITAL BIOMANUFACTURING MARKET SIZE, BY UPSTREAM PROCESSING, 2018-2030 (USD MILLION)
TABLE 193. RUSSIA DIGITAL BIOMANUFACTURING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 194. RUSSIA DIGITAL BIOMANUFACTURING MARKET SIZE, BY SINGLE-USE SYSTEMS, 2018-2030 (USD MILLION)
TABLE 195. RUSSIA DIGITAL BIOMANUFACTURING MARKET SIZE, BY TRADITIONAL SYSTEMS, 2018-2030 (USD MILLION)
TABLE 196. RUSSIA DIGITAL BIOMANUFACTURING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 197. RUSSIA DIGITAL BIOMANUFACTURING MARKET SIZE, BY ACADEMIC ORGANIZATIONS, 2018-2030 (USD MILLION)
TABLE 198. RUSSIA DIGITAL BIOMANUFACTURING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 199. RUSSIA DIGITAL BIOMANUFACTURING MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 200. ITALY DIGITAL BIOMANUFACTURING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 201. ITALY DIGITAL BIOMANUFACTURING MARKET SIZE, BY CELL THERAPY, 2018-2030 (USD MILLION)
TABLE 202. ITALY DIGITAL BIOMANUFACTURING MARKET SIZE, BY PROCESS STAGE, 2018-2030 (USD MILLION)
TABLE 203. ITALY DIGITAL BIOMANUFACTURING MARKET SIZE, BY CONTINUOUS BIOMANUFACTURING, 2018-2030 (USD MILLION)
TABLE 204. ITALY DIGITAL BIOMANUFACTURING MARKET SIZE, BY DOWNSTREAM PROCESSING, 2018-2030 (USD MILLION)
TABLE 205. ITALY DIGITAL BIOMANUFACTURING MARKET SIZE, BY UPSTREAM PROCESSING, 2018-2030 (USD MILLION)
TABLE 206. ITALY DIGITAL BIOMANUFACTURING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 207. ITALY DIGITAL BIOMANUFACTURING MARKET SIZE, BY SINGLE-USE SYSTEMS, 2018-2030 (USD MILLION)
TABLE 208. ITALY DIGITAL BIOMANUFACTURING MARKET SIZE, BY TRADITIONAL SYSTEMS, 2018-2030 (USD MILLION)
TABLE 209. ITALY DIGITAL BIOMANUFACTURING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 210. ITALY DIGITAL BIOMANUFACTURING MARKET SIZE, BY ACADEMIC ORGANIZATIONS, 2018-2030 (USD MILLION)
TABLE 211. ITALY DIGITAL BIOMANUFACTURING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 212. ITALY DIGITAL BIOMANUFACTURING MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 213. SPAIN DIGITAL BIOMANUFACTURING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 214. SPAIN DIGITAL BIOMANUFACTURING MARKET SIZE, BY CELL THERAPY, 2018-2030 (USD MILLION)
TABLE 215. SPAIN DIGITAL BIOMANUFACTURING MARKET SIZE, BY PROCESS STAGE, 2018-2030 (USD MILLION)
TABLE 216. SPAIN DIGITAL BIOMANUFACTURING MARKET SIZE, BY CONTINUOUS BIOMANUFACTURING, 2018-2030 (USD MILLION)
TABLE 217. SPAIN DIGITAL BIOMANUFACTURING MARKET SIZE, BY DOWNSTREAM PROCESSING, 2018-2030 (USD MILLION)
TABLE 218. SPAIN DIGITAL BIOMANUFACTURING MARKET SIZE, BY UPSTREAM PROCESSING, 2018-2030 (USD MILLION)
TABLE 219. SPAIN DIGITAL BIOMANUFACTURING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 220. SPAIN DIGITAL BIOMANUFACTURING MARKET SIZE, BY SINGLE-USE SYSTEMS, 2018-2030 (USD MILLION)
TABLE 221. SPAIN DIGITAL BIOMANUFACTURING MARKET SIZE, BY TRADITIONAL SYSTEMS, 2018-2030 (USD MILLION)
TABLE 222. SPAIN DIGITAL BIOMANUFACTURING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 223. SPAIN DIGITAL BIOMANUFACTURING MARKET SIZE, BY ACADEMIC ORGANIZATIONS, 2018-2030 (USD MILLION)
TABLE 224. SPAIN DIGITAL BIOMANUFACTURING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 225. SPAIN DIGITAL BIOMANUFACTURING MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 226. UNITED ARAB EMIRATES DIGITAL BIOMANUFACTURING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 227. UNITED ARAB EMIRATES DIGITAL BIOMANUFACTURING MARKET SIZE, BY CELL THERAPY, 2018-2030 (USD MILLION)
TABLE 228. UNITED ARAB EMIRATES DIGITAL BIOMANUFACTURING MARKET SIZE, BY PROCESS STAGE, 2018-2030 (USD MILLION)
TABLE 229. UNITED ARAB EMIRATES DIGITAL BIOMANUFACTURING MARKET SIZE, BY CONTINUOUS BIOMANUFACTURING, 2018-2030 (USD MILLION)
TABLE 230. UNITED ARAB EMIRATES DIGITAL BIOMANUFACTURING MARKET SIZE, BY DOWNSTREAM PROCESSING, 2018-2030 (USD MILLION)
TABLE 231. UNITED ARAB EMIRATES DIGITAL BIOMANUFACTURING MARKET SIZE, BY UPSTREAM PROCESSING, 2018-2030 (USD MILLION)
TABLE 232. UNITED ARAB EMIRATES DIGITAL BIOMANUFACTURING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 233. UNITED ARAB EMIRATES DIGITAL BIOMANUFACTURING MARKET SIZE, BY SINGLE-USE SYSTEMS, 2018-2030 (USD MILLION)
TABLE 234. UNITED ARAB EMIRATES DIGITAL BIOMANUFACTURING MARKET SIZE, BY TRADITIONAL SYSTEMS, 2018-2030 (USD MILLION)
TABLE 235. UNITED ARAB EMIRATES DIGITAL BIOMANUFACTURING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 236. UNITED ARAB EMIRATES DIGITAL BIOMANUFACTURING MARKET SIZE, BY ACADEMIC ORGANIZATIONS, 2018-2030 (USD MILLION)
TABLE 237. UNITED ARAB EMIRATES DIGITAL BIOMANUFACTURING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 238. UNITED ARAB EMIRATES DIGITAL BIOMANUFACTURING MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 239. SAUDI ARABIA DIGITAL BIOMANUFACTURING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 240. SAUDI ARABIA DIGITAL BIOMANUFACTURING MARKET SIZE, BY CELL THERAPY, 2018-2030 (USD MILLION)
TABLE 241. SAUDI ARABIA DIGITAL BIOMANUFACTURING MARKET SIZE, BY PROCESS STAGE, 2018-2030 (USD MILLION)
TABLE 242. SAUDI ARABIA DIGITAL BIOMANUFACTURING MARKET SIZE, BY CONTINUOUS BIOMANUFACTURING, 2018-2030 (USD MILLION)
TABLE 243. SAUDI ARABIA DIGITAL BIOMANUFACTURING MARKET SIZE, BY DOWNSTREAM PROCESSING, 2018-2030 (USD MILLION)
TABLE 244. SAUDI ARABIA DIGITAL BIOMANUFACTURING MARKET SIZE, BY UPSTREAM PROCESSING, 2018-2030 (USD MILLION)
TABLE 245. SAUDI ARABIA DIGITAL BIOMANUFACTURING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 246. SAUDI ARABIA DIGITAL BIOMANUFACTURING MARKET SIZE, BY SINGLE-USE SYSTEMS, 2018-2030 (USD MILLION)
TABLE 247. SAUDI ARABIA DIGITAL BIOMANUFACTURING MARKET SIZE, BY TRADITIONAL SYSTEMS, 2018-2030 (USD MILLION)
TABLE 248. SAUDI ARABIA DIGITAL BIOMANUFACTURING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 249. SAUDI ARABIA DIGITAL BIOMANUFACTURING MARKET SIZE, BY ACADEMIC ORGANIZATIONS, 2018-2030 (USD MILLION)
TABLE 250. SAUDI ARABIA DIGITAL BIOMANUFACTURING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 251. SAUDI ARABIA DIGITAL BIOMANUFACTURING MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 252. SOUTH AFRICA DIGITAL BIOMANUFACTURING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 253. SOUTH AFRICA DIGITAL BIOMANUFACTURING MARKET SIZE, BY CELL THERAPY, 2018-2030 (USD MILLION)
TABLE 254. SOUTH AFRICA DIGITAL BIOMANUFACTURING MARKET SIZE, BY PROCESS STAGE, 2018-2030 (USD MILLION)
TABLE 255. SOUTH AFRICA DIGITAL BIOMANUFACTURING MARKET SIZE, BY CONTINUOUS BIOMANUFACTURING, 2018-2030 (USD MILLION)
TABLE 256. SOUTH AFRICA DIGITAL BIOMANUFACTURING MARKET SIZE, BY DOWNSTREAM PROCESSING, 2018-2030 (USD MILLION)
TABLE 257. SOUTH AFRICA DIGITAL BIOMANUFACTURING MARKET SIZE, BY UPSTREAM PROCESSING, 2018-2030 (USD MILLION)
TABLE 258. SOUTH AFRICA DIGITAL BIOMANUFACTURING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 259. SOUTH AFRICA DIGITAL BIOMANUFACTURING MARKET SIZE, BY SINGLE-USE SYSTEMS, 2018-2030 (USD MILLION)
TABLE 260. SOUTH AFRICA DIGITAL BIOMANUFACTURING MARKET SIZE, BY TRADITIONAL SYSTEMS, 2018-2030 (USD MILLION)
TABLE 261. SOUTH AFRICA DIGITAL BIOMANUFACTURING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 262. SOUTH AFRICA DIGITAL BIOMANUFACTURING MARKET SIZE, BY ACADEMIC ORGANIZATIONS, 2018-2030 (USD MILLION)
TABLE 263. SOUTH AFRICA DIGITAL BIOMANUFACTURING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 264. SOUTH AFRICA DIGITAL BIOMANUFACTURING MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 265. DENMARK DIGITAL BIOMANUFACTURING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 266. DENMARK DIGITAL BIOMANUFACTURING MARKET SIZE, BY CELL THERAPY, 2018-2030 (USD MILLION)
TABLE 267. DENMARK DIGITAL BIOMANUFACTURING MARKET SIZE, BY PROCESS STAGE, 2018-2030 (USD MILLION)
TABLE 268. DENMARK DIGITAL BIOMANUFACTURING MARKET SIZE, BY CONTINUOUS BIOMANUFACTURING, 2018-2030 (USD MILLION)
TABLE 269. DENMARK DIGITAL BIOMANUFACTURING MARKET SIZE, BY DOWNSTREAM PROCESSING, 2018-2030 (USD MILLION)
TABLE 270. DENMARK DIGITAL BIOMANUFACTURING MARKET SIZE, BY UPSTREAM PROCESSING, 2018-2030 (USD MILLION)
TABLE 271. DENMARK DIGITAL BIOMANUFACTURING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 272. DENMARK DIGITAL BIOMANUFACTURING MARKET SIZE, BY SINGLE-USE SYSTEMS, 2018-2030 (USD MILLION)
TABLE 273. DENMARK DIGITAL BIOMANUFACTURING MARKET SIZE, BY TRADITIONAL SYSTEMS, 2018-2030 (USD MILLION)
TABLE 274. DENMARK DIGITAL BIOMANUFACTURING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 275. DENMARK DIGITAL BIOMANUFACTURING MARKET SIZE, BY ACADEMIC ORGANIZATIONS, 2018-2030 (USD MILLION)
TABLE 276. DENMARK DIGITAL BIOMANUFACTURING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 277. DENMARK DIGITAL BIOMANUFACTURING MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 278. NETHERLANDS DIGITAL BIOMANUFACTURING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 279. NETHERLANDS DIGITAL BIOMANUFACTURING MARKET SIZE, BY CELL THERAPY, 2018-2030 (USD MILLION)
TABLE 280. NETHERLANDS DIGITAL BIOMANUFACTURING MARKET SIZE, BY PROCESS STAGE, 2018-2030 (USD MILLION)
TABLE 281. NETHERLANDS DIGITAL BIOMANUFACTURING MARKET SIZE, BY CONTINUOUS BIOMANUFACTURING, 2018-2030 (USD MILLION)
TABLE 282. NETHERLANDS DIGITAL BIOMANUFACTURING MARKET SIZE, BY DOWNSTREAM PROCESSING, 2018-2030 (USD MILLION)
TABLE 283. NETHERLANDS DIGITAL BIOMANUFACTURING MARKET SIZE, BY UPSTREAM PROCESSING, 2018-2030 (USD MILLION)
TABLE 284. NETHERLANDS DIGITAL BIOMANUFACTURING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 285. NETHERLANDS DIGITAL BIOMANUFACTURING MARKET SIZE, BY SINGLE-USE SYSTEMS, 2018-2030 (USD MILLION)
TABLE 286. NETHERLANDS DIGITAL BIOMANUFACTURING MARKET SIZE, BY TRADITIONAL SYSTEMS, 2018-2030 (USD MILLION)
TABLE 287. NETHERLANDS DIGITAL BIOMANUFACTURING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 288. NETHERLANDS DIGITAL BIOMANUFACTURING MARKET SIZE, BY ACADEMIC ORGANIZATIONS, 2018-2030 (USD MILLION)
TABLE 289. NETHERLANDS DIGITAL BIOMANUFACTURING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 290. NETHERLANDS DIGITAL BIOMANUFACTURING MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 291. QATAR DIGITAL BIOMANUFACTURING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 292. QATAR DIGITAL BIOMANUFACTURING MARKET SIZE, BY CELL THERAPY, 2018-2030 (USD MILLION)
TABLE 293. QATAR DIGITAL BIOMANUFACTURING MARKET SIZE, BY PROCESS STAGE, 2018-2030 (USD MILLION)
TABLE 294. QATAR DIGITAL BIOMANUFACTURING MARKET SIZE, BY CONTINUOUS BIOMANUFACTURING, 2018-2030 (USD MILLION)
TABLE 295. QATAR DIGITAL BIOMANUFACTURING MARKET SIZE, BY DOWNSTREAM PROCESSING, 2018-2030 (USD MILLION)
TABLE 296. QATAR DIGITAL BIOMANUFACTURING MARKET SIZE, BY UPSTREAM PROCESSING, 2018-2030 (USD MILLION)
TABLE 297. QATAR DIGITAL BIOMANUFACTURING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 298. QATAR DIGITAL BIOMANUFACTURING MARKET SIZE, BY SINGLE-USE SYSTEMS, 2018-2030 (USD MILLION)
TABLE 299. QATAR DIGITAL BIOMANUFACTURING MARKET SIZE, BY TRADITIONAL SYSTEMS, 2018-2030 (USD MILLION)
TABLE 300. QATAR DIGITAL BIOMANUFACTURING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 301. QATAR DIGITAL BIOMANUFACTURING MARKET SIZE, BY ACADEMIC ORGANIZATIONS, 2018-2030 (USD MILLION)
TABLE 302. QATAR DIGITAL BIOMANUFACTURING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 303. QATAR DIGITAL BIOMANUFACTURING MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 304. FINLAND DIGITAL BIOMANUFACTURING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 305. FINLAND DIGITAL BIOMANUFACTURING MARKET SIZE, BY CELL THERAPY, 2018-2030 (USD MILLION)
TABLE 306. FINLAND DIGITAL BIOMANUFACTURING MARKET SIZE, BY PROCESS STAGE, 2018-2030 (USD MILLION)
TABLE 307. FINLAND DIGITAL BIOMANUFACTURING MARKET SIZE, BY CONTINUOUS BIOMANUFACTURING, 2018-2030 (USD MILLION)
TABLE 308. FINLAND DIGITAL BIOMANUFACTURING MARKET SIZE, BY DOWNSTREAM PROCESSING, 2018-2030 (USD MILLION)
TABLE 309. FINLAND DIGITAL BIOMANUFACTURING MARKET SIZE, BY UPSTREAM PROCESSING, 2018-2030 (USD MILLION)
TABLE 310. FINLAND DIGITAL BIOMANUFACTURING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 311. FINLAND DIGITAL BIOMANUFACTURING MARKET SIZE, BY SINGLE-USE SYSTEMS, 2018-2030 (USD MILLION)
TABLE 312. FINLAND DIGITAL BIOMANUFACTURING MARKET SIZE, BY TRADITIONAL SYSTEMS, 2018-2030 (USD MILLION)
TABLE 313. FINLAND DIGITAL BIOMANUFACTURING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 314. FINLAND DIGITAL BIOMANUFACTURING MARKET SIZE, BY ACADEMIC ORGANIZATIONS, 2018-2030 (USD MILLION)
TAB

Samples

Loading
LOADING...

Companies Mentioned

The companies profiled in this Digital Biomanufacturing market report include:
  • Thermo Fisher Scientific Inc.
  • Sartorius AG
  • Merck KGaA
  • Danaher Corporation
  • Eppendorf AG
  • Agilent Technologies, Inc.
  • Bio-Rad Laboratories, Inc.
  • PerkinElmer, Inc.
  • Shimadzu Corporation
  • Rockwell Automation, Inc.

Table Information

Report AttributeDetails
No. of Pages185
PublishedMay 2025
Forecast Period2025 - 2030
Estimated Market Value ( USD ) in 2025 $ 20.9 Billion
Forecasted Market Value ( USD ) by 2030 $ 33.16 Billion
Compound Annual Growth Rate9.7%
Regions CoveredGlobal
No. of Companies Mentioned11

Related Topics

Related Reports

Next-Generation Biomanufacturing Market by Product Type, Technology, Process Stage, End User, Operation Scale, Cell Line, Process Mode - Global Forecast to 2030 - Product Image

Next-Generation Biomanufacturing Market by Product Type, Technology, Process Stage, End User, Operation Scale, Cell Line, Process Mode - Global Forecast to 2030

  • Report
  • 193 Pages
  • Global
From
Cell & Gene Therapy Biomanufacturing CDMO Market by Service Type, Therapy Type, Technology, Application, Scale, End User, Process Stage - Global Forecast to 2030 - Product Image

Cell & Gene Therapy Biomanufacturing CDMO Market by Service Type, Therapy Type, Technology, Application, Scale, End User, Process Stage - Global Forecast to 2030

  • Report
  • 188 Pages
  • Global
From
Digital Biomanufacturing - Global Strategic Business Report - Product Image

Digital Biomanufacturing - Global Strategic Business Report

  • Report
  • 341 Pages
  • Global
From
Biomanufacturing - Global Strategic Business Report - Product Image

Biomanufacturing - Global Strategic Business Report

  • Report
  • 375 Pages
  • Global
From
Digital Biomanufacturing Market Report and Forecast 2025-2034 - Product Image

Digital Biomanufacturing Market Report and Forecast 2025-2034

  • Report
  • 400 Pages
  • Global
From

About the Market

Digital Biomanufacturing is a subset of biotechnology that focuses on the use of digital technologies to improve the efficiency and effectiveness of biomanufacturing processes. It involves the integration of digital technologies such as artificial intelligence, machine learning, and the Internet of Things (IoT) into biomanufacturing processes. This integration enables the automation of processes, the optimization of production, and the collection of data for analysis and decision-making. Digital Biomanufacturing also enables the development of new products and services, such as personalized medicines and cell therapies. Companies in the Digital Biomanufacturing market include G-CON Manufacturing, Inc., Cytiva, Thermo Fisher Scientific, Merck KGaA, and GE Healthcare. Show Less Read more

Copyright © 2002-2025 Research and Markets. All Rights Reserved.